These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18214801)

  • 1. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells.
    Fan YY; Yang BY; Wu CY
    Immunol Invest; 2008; 37(1):79-96. PubMed ID: 18214801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY; Yang BY; Wu CY
    Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
    Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
    Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections.
    Dalle JH; Menezes J; Wagner E; Blagdon M; Champagne J; Champagne MA; Duval M
    Pediatr Res; 2005 May; 57(5 Pt 1):649-55. PubMed ID: 15718362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expansion of umbilical cord blood mononuclear cell-derived natural killer cells dependent on the dose of interleukin-15 with Flt3L.
    Nagamura-Inoue T; Mori Y; Yizhou Z; Watanabe N; Takahashi TA
    Exp Hematol; 2004 Feb; 32(2):202-9. PubMed ID: 15102482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2-activated cord blood mononuclear cells.
    Derzic S; Slone V; Sender L
    Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
    Luevano M; Daryouzeh M; Alnabhan R; Querol S; Khakoo S; Madrigal A; Saudemont A
    Hum Immunol; 2012 Mar; 73(3):248-57. PubMed ID: 22234167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
    Saghafi S; Pourfathollah AA; Kheirandish M; Azimdoust A; Behnia M; Shahjahani M; Moin M
    Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):69-77. PubMed ID: 20683100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of CD27 as a marker for distinguishing human NK cell subsets.
    Silva A; Andrews DM; Brooks AG; Smyth MJ; Hayakawa Y
    Int Immunol; 2008 Apr; 20(4):625-30. PubMed ID: 18326863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
    Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
    Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.